Literature DB >> 23598266

Ambulation and multiple sclerosis.

Robert W Motl1.   

Abstract

Walking impairment is a common consequence of multiple sclerosis (MS) that can result in substantial limitations of daily activities and compromised quality of life. Walking impairment is often monitored as an indicator of disease and neurologic disability progression. The worsening of walking performance while undertaking a cognitive task underscores the role of nonmotor impairments in ambulation limitations. Walking impairment has ubiquitous and life-altering consequences, underscoring the importance of continued efforts to identify approaches to prevent and forestall this event, and to restore walking ability in persons with MS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23598266     DOI: 10.1016/j.pmr.2012.11.004

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  15 in total

1.  Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.

Authors:  Brian M Sandroff; Lara A Pilutti; Deirdre Dlugonski; Yvonne C Learmonth; John H Pula; Robert W Motl
Journal:  Int J MS Care       Date:  2014

Review 2.  Therapies for mobility disability in persons with multiple sclerosis.

Authors:  Jessica F Baird; Brian M Sandroff; Robert W Motl
Journal:  Expert Rev Neurother       Date:  2018-05-30       Impact factor: 4.618

3.  Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.

Authors:  Brian M Sandroff; Stephanie L Silveira; Jessica F Baird; Trinh Huynh; Robert W Motl
Journal:  Phys Ther       Date:  2021-02-04

4.  Clinical importance of steps taken per day among persons with multiple sclerosis.

Authors:  Robert W Motl; Lara A Pilutti; Yvonne C Learmonth; Myla D Goldman; Ted Brown
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

5.  Monitoring gait in multiple sclerosis with novel wearable motion sensors.

Authors:  Yaejin Moon; Ryan S McGinnis; Kirsten Seagers; Robert W Motl; Nirav Sheth; John A Wright; Roozbeh Ghaffari; Jacob J Sosnoff
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

6.  A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.

Authors:  Ryan S McGinnis; Nikhil Mahadevan; Yaejin Moon; Kirsten Seagers; Nirav Sheth; John A Wright; Steven DiCristofaro; Ikaro Silva; Elise Jortberg; Melissa Ceruolo; Jesus A Pindado; Jacob Sosnoff; Roozbeh Ghaffari; Shyamal Patel
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

7.  Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.

Authors:  Robert W Motl; Jeffrey A Cohen; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

8.  Integrity of the anterior visual pathway and its association with ambulatory performance in multiple sclerosis.

Authors:  Swathi Balantrapu; Brian M Sandroff; John H Pula; Robert W Motl
Journal:  Mult Scler Int       Date:  2013-06-24

9.  Effects of walking direction and cognitive challenges on gait in persons with multiple sclerosis.

Authors:  Douglas A Wajda; Brian M Sandroff; John H Pula; Robert W Motl; Jacob J Sosnoff
Journal:  Mult Scler Int       Date:  2013-10-07

10.  Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the Step it Up study.

Authors:  Sara Hayes; Marcin Kacper Uszynski; Robert W Motl; Stephen Gallagher; Aidan Larkin; John Newell; Carl Scarrott; Susan Coote
Journal:  BMJ Open       Date:  2017-10-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.